Regenerative Medical Technology (RMTG) EBITDA (2019 - 2026)
Regenerative Medical Technology's EBITDA came in at $1 million for Q2 2026, compared with -$195,255 a year earlier and down 5.2% from the prior quarter.
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regenerative Medical Technology reported EBITDA of $2.79 million, up 433.2% year-over-year; for FY2025, it was $780,196, down 67.9% from FY2024.
- EBITDA carries a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- Going back by year, EBITDA was $2.43 million in FY2024 (-8.5%), $2.65 million in FY2023 (+266.4%), $724,644 in FY2022 and -$8.98 million in FY2021.
- The five-year range for quarterly EBITDA is -$8.72 million (Q3 2021) to $1.06 million (Q1 2026).
- Year-over-year, EBITDA increased in two of the last six quarters, with growth averaging 50.7%.
- The fastest year-over-year change in EBITDA over five years came in Q1 2026 (growth of 466.1%), and the weakest in Q1 2025 (a decline of 81.3%).
- Business Quant data shows RMTG's EBITDA at $1.06 million (Q1 2026), $582,083 (Q4 2025) and $148,730 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Regenerative Medical Technology | 412,169.03 | -4.11 Mn | 2.58 Mn | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 582,083.00 |
| Sep 30, 2025 | 148,730.00 |
| Jun 30, 2025 | -195,255.00 |
| Mar 31, 2025 | 186,774.00 |
| Dec 31, 2024 | 357,193.00 |
| Sep 30, 2024 | 174,552.00 |
| Jun 30, 2024 | 900,429.00 |
| Mar 31, 2024 | 996,245.00 |
| Dec 31, 2023 | 725,977.00 |
| Sep 30, 2023 | 788,266.00 |
| Jun 30, 2023 | 392,167.00 |
| Mar 31, 2023 | 748,380.00 |
| Dec 31, 2022 | 372,935.00 |
| Sep 30, 2022 | 313,389.00 |
| Jun 30, 2022 | 108,605.00 |
| Mar 31, 2022 | -70,285.00 |
| Dec 31, 2021 | -75,433.00 |
| Sep 30, 2021 | -8.72 Mn |
API Access
Regenerative Medical Technology EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();